Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q4 FY22 results · Jan–Mar 2022

Advanced Enzyme Technologies reported revenue from operations of ₹131.73 crore (down 1.1% from Q4 FY21) and net profit of ₹25.25 crore (down 25.3% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY22Q4 FY21YoYQ3 FY22QoQ
Revenue from operations131.73133.22−1.1%133.56−1.4%
Other income3.381.68+101.0%1.21+180.4%
Total income135.12134.90+0.2%134.76+0.3%
Profit before tax33.9547.77−28.9%41.12−17.5%
Net profit for the period25.2533.80−25.3%28.55−11.6%
Attributable to shareholders of the company24.4331.68−22.9%27.48−11.1%
EPS, basic (₹)2.192.84−22.9%2.46−11.0%
Net margin (%)19.225.421.4
Standalone · ₹ crore
ItemQ4 FY22Q4 FY21YoYQ3 FY22QoQ
Revenue from operations70.7570.61+0.2%64.39+9.9%
Other income5.172.58+100.0%1.07+384.9%
Total income75.9273.19+3.7%65.45+16.0%
Profit before tax17.9722.07−18.6%11.78+52.6%
Net profit for the period14.3515.24−5.8%8.77+63.6%
EPS, basic (₹)1.281.37−6.6%0.78+64.1%
Net margin (%)20.321.613.6
Consolidated
Filed with BSE
21 May 2022, 14:06 IST
Board meeting
20 May 2022
Period
01 Jan 2022 to 31 Mar 2022
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
21 May 2022, 14:06 IST
Board meeting
20 May 2022
Period
01 Jan 2022 to 31 Mar 2022
Review status
Audited
Source
XBRL filing on BSE